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Abstract. Adult male rats were implanted with in- 
traventricular (ivt.) brain cannulae for injection of 5 ~tg of 
acetylseco-hemicholinium-3 (acetylseco HC-3) as a means 
of studying acetylcholine (ACh) utilization during morphine 
withdrawal. Animals were made dependent by implanting 
s.c. two 75 mg morphine base pellets 24 hrs apart. On the 
4th day animals were given 10 mg/kg of naloxone i.p. and/or 
5 ~g acetylseco HC-3 ivt. and sacrificed by decapitation at 
various times. The brains were removed and assayed for 
ACh using a pyrolysis gas chromatographic procedure. Total 
brain ACh before or after acetylseco-HC-3 was not altered 
at 5, 30, 60 and 120 but was decreased at 10 min after nalo- 
xone. These results are in sharp contrast to our previous 
data of enhanced brain ACh utilization in withdrawn rats 
made dependent to morphine by several weeks of twice daily 
injections. It is apparent that short term morphine pellet 
administration does not produce the marked neurochemical 
and behavioral changes of long term morphine injections. 
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The pellet method of studying morphine tolerance and 
withdrawal is now widely used because of rapidity of 
tolerance development and obvious convenience to 
investigators (Way et at., 1969; Wei, 1972). Recently, 
Cheney and Hanin (1973) reported that acute mor- 
phine administration reduced mouse brain acetylcho- 
line (ACh) turnover. They were able to show rapid 
tolerance development to this phenomenon in mor- 
phine pellet implanted animals. Their elegant studies 
of brain ACh turnover confirmed our previous find- 
ings (Domino and Wilson, 1973 a) in the rat using 
indirect means of measuring ACh utilization via in- 
traventricular (ivt.) hemicholinium-3 (HC-3) induced 
ACh depletion and its antagonism by morphine and 
other narcotic agonists. We also reported that during 
morphine withdrawal in dependent rats previously 
given the drug bid for 8-12 weeks there was increased 
utilization and a decrease in total brain ACh (Domino 
and Wilson, 1973b). Using a different approach 
Large and Milton (1970) came to a similar conclusion. 
Recently, Bhargava and Way (1974) showed that 
brain ACh is reduced in morphine pellet treated mice 
and rats given naloxone, and that the ACh decrease 
was associated with increased jumping during with- 
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drawal. Hence, it was quite surprising that Cheney 
and Hanin were unable to show any change in brain 
ACh turnover in morphine pellet implanted mice 15 
rain after naloxone injection. We argued that one must 
study the complete time course of narcotic withdrawal 
for a biphasic effect on ACh release is known to occur 
(Labrecque and Domino, 1973). Thus, 15 rain may 
be the critical inflection point for no change in ACh 
turnover. Nevertheless, the Cheney and Hanin study 
was sufficiently disturbing to cause us to reexamine 
the problem in morphine pellet rats using those tech- 
niques of ACh utilization with which we are familiar. 
The present manuscript describes findings in the 
rat which are similar to those obtained by Cheney and 
Hanin, as well as Bhargava and Way in the mouse 
and rat. However, our data raises serious questions 
regarding the significance of short term morphine pel- 
let implantation as a means of studying morphine de- 
pendence. 
Methods  
Male Holtzman rats 250-300 g were housed 6 to 10 in group 
cages under previously described conditions (Domino and 
Wilson, 1973a, b). Rats were used one week after implanta- 
tion with ivt. polyethylene cannulas by the method of Ro- 
binson et al. (1969) and Altaffer et al. (1970). Rats receiving 
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morphine (75 mg base) pellets were implanted 3 days prior 
to use by the method of Wei (1972). Two pellets were im- 
planted 24 hrs apart. In one series the pellets were not re- 
moved and during another they were removed 6 hrs prior 
to withdrawal. Withdrawal was precipitated by 10 mg/kg of 
naloxone hydrochloride i.p. calculated as base. Acetylseco 
hemicholinium-3 (acetylseco HC-3) was given to unan- 
esthetized slightly restrained rats via the ivt. cannula 1/2 hr 
prior to sacrifice. All animals were guillotined at approxi- 
mately the same time (8:00-9:00 a.m.) each day. Rat brain 
ACh was determined by gas liquid chromatography per the 
methods of Schmidt etal. (1972) and Szilagyi et al. (1972). 
After guillotine, brains were removed and homogenized in 
acetonitrile with 25 nmol of proprionylcholine as internal 
standard. A Hewlett Packard 5750 gas chromatograph with 
8 ft. by 1/4 in. stainless steel columns packed with 20 % Car- 
bowax 6000 on 60/80 mesh Chromasorb W (HMDS) was 
used for analysis. 
Resul t s  
In Table i are given mean  brain A C h  _+ S. E. in nmol/g 
wet weight after various procedures  .It should be noted 
that mean  brain ACh  + S.E. of control animals was 
18.1 + 1.3 with the Schmidt et al. procedure and 24.6 
+ 0.7 with the Szilagyi et al. procedure.  Rats which 
received no t rea tment  of any kind did not significantly 
differ in brain A C h  from those that were cannulated, 
contained morphine pellets for 72 hrs or sham pellet 
rats that received 10 mg/kg naloxone l/2 hr prior to 
sacrifice. The ivt. injection of 5~tg of acetylseco HC-3  
to control animals caused a significant decrease in 
brain ACh  to 10.1 _+ 0.6 nmol/g. This dose of acetyl- 
seco HC-3  was chosen because it gave a mode ra t e  
depletion of rat brain ACh  which could be used as 
an indirect indicator of ACh  utilization (Domino and 
Wilson, 1973 a, b). Mean brain ACh  + S.E. at various 
times of withdrawal with and without 5 ~g ivt. acetyl- 
seco HC-3  are also given in Table 1. When 72 hrs 
morphine pellet rats received 10 mg/kg naloxone 
there was no significant change in brain ACh  at z~ z hr 
whether  the pellet was present  or had been removed 
6 hrs previously. During the first 4 min after naloxone 
animals exhibited exploratory behavior,  wet shakes, 
blanching of ears and tachypnea. A marked  sedation 
was observed 5-8  min later with diarrhea, vocalization 
on touch, rhinorrhea and ptosis. Morphine pellet rats 
given 5 ~tg ivt. acetylseco HC-3  in addition to nalo- 
xone exhibited similar signs. Brain ACh  was decreased 
but not significantly above or below levels of brain 
ACh after 5 ~tg of ivt. acetylseco HC-3  given alone 
to control animals. Only 10 min after naloxone was 
there a significant decrease in brain ACh  in the mor-  
phine pellet animals. 
Table 1. Mean brain ACh _+ S.E. nmol/g 
Treatment Alone Plus 5 Bg ivt. acetylseco HC-3 
N A N B 
p value p value 
Sehmidt et al., ACh assay 
Controls 13 18.1 +_ 1.3 NS 
Morphine pellet (72 hrs) 8 18.4 __ 0.7 NS 
Cannulated rats 8 18.2 _+ 0.4 NS 
Sham pellet, 10 mg/kg naloxone 8 18.6 _+ 0.3 NS 
Sham pellet, 10 mg/kg naloxone pellet removed 8 17.7 _+ 0.9 NS 
1/2 ~hr withdrawal, 10 mg/kg naloxone pellet 
not removed 17 18.9 _+ 2.4 NS 
1/2 hr withdrawal, 10 mg/kg naloxone pellet 
removed 8 16.4 _+ 0.5 NS 
1 hr withdrawal, 10 mg/kg naloxone pellet 
not removed 8 19.6 _+ 0.7 NS 
2 hrs withdrawal, 10 mg/kg naloxone pellet 
not removed 8 18.6 _+ 1.1 NS 
Szilagyi et al., ACh assay 
Controls 7 24.6 __ 0.7 NS 
5 min withdrawal, 10 mg/kg naloxone pellet 
not removed 8 23.5 _+ 0.6 NS 
10 rain withdrawal, 10 mg/kg naloxone pellet 
not removed 8 21.6 _ 0.7 <0.05 
- - N S  
- - NS 
9 10.1 _+ 0.6 <0.001 
7 10.1 _+ 0.3 <0.001 
9 11.2 + 0.5 <0.001 
8 10.1 _+ 0.4 <0.001 
7 11.0 + 0.4 <0.001 
14 14.2 _+ 0.5 NS 
7 13.1 __ 0.6 NS 
9 14.0 _+ 0.6 NS 
A Group comparison Student " t"  tests of appropriate control vs withdrawn rats. 
B Group comparison Student " t"  tests of alone vs rats with 5 Bg ivt. acetylseco HC-3. 
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Discussion 
The rat brain ACh levels of pellet animals during mor- 
phine withdrawal differ considerably with those we 
found in withdrawing rats given weeks of morphine 
by injection (Domino and Wilson, 1973 a, b). Instead 
of a decrease, there was no change in the morphine 
pellet present or the morphine pellet absent animals 
5, 30, 60 and 120 min after naloxone. Only 10 min 
after naloxone were total brain ACh levels reduced 
in the morphine pellet animals ( P <  0.05). There was 
no significant change in brain ACh utilization as mea- 
sured indirectly by acetylseco HC-3. The morphine 
pellet present or absent rats given naloxone showed 
obvious withdrawal since their signs corresponded to 
those described by Wei (1972). Rats did not show 
any withdrawal symptoms 6 hrs after pellet removal. 
The major deficiency of this study was our failure to 
quantify the degree of morphine withdrawal the an- 
imals were experiencing. This is especially critical in 
view of the observation by Bhargava and Way (1974) 
that only rodents which jumped during morphine 
withdrawal showed decreased brain ACh levels. 
Naturally withdrawn rats after weeks of a narcotic 
agonist show an increase in motor activity (Akera and 
Brody, 1969; Martin et al., 1963). On the other hand, 
rats tolerant to morphine via injection or pellet im- 
plantation given a narcotic antagonist show immobility 
(Kaymakcalan and Woods, 1956; Large, 1972; Wei, 
1972) with return to normal activity. Rats undergoing 
withdrawal after weeks of a narcotic agonist ex- 
perience prolonged stress. In our morphine pellet an- 
imals at the end of 2 hrs of withdrawal there was a 
6-8 % weight loss. In our naturally withdrawn chron- 
ically treated rats there was a 14-20% weight loss 
after 48 hrs. Akera and Brody (1969) have noted that 
at 48 hrs withdrawal symptoms were most prominent 
in such chronic morphine dependent animals. Tilson 
et al. (1973) have also described the greatest decrease 
in nociceptive threshold at this time. 
It should be noted that Colasanti et al. (1974) 
found that 72 hrs morphine pellet implanted rats upon 
removal of the pellets show much shorter rebound 
REM sleep time during abstinence than after pro- 
longed i.v. morphine (Khazan and Colasanti, 1972). 
These investigators concluded that their i.v. method 
produces a greater degree of drug dependence. 
Recently, Bl~isig et al. (1973) have studied the devel- 
opment of physical dependence on morphine in rats 
implanted s.c. with morphine containing pellets in 
which the dosage, frequency of implantation, and du- 
ration of exposure to morphine were varied. These 
investigators showed that the various signs of pre- 
cipitated withdrawal do not all increase concomitantly 
with increasing dependence. It is therefore quite pos- 
sible that observed changes in ACh turnover are asso- 
ciated with the manifestation of a particular behavior 
rather than an underlying physiological mechanism 
relevant to physical dependence per  se. 
It appears that morphine withdrawal after pellet 
implantation, while producing many of the physical 
signs of withdrawal, does not affect brain ACh similar 
to rats receiving morphine over many weeks. The 
symptoms are on entirely different time scales and 
much more compressed in the pellet withdrawing rats. 
In addition, dependent rats given morphine by in- 
jection show excitation immediately after the mor- 
phine. Such rats subjected to prolonged exposure to 
morphine, whether withdrawal is by an antagonist or 
naturally, have different brain levels of ACh than pel- 
let withdrawing animals given an antagonist. Large 
(1972) found that nalorphine precipitated abstinence 
in tolerant rats may be manifested by either ex- 
citement or depression, depending on frequency of 
injection, the strain of the rats, whether they received 
a regular dose of morphine before the antagonist, or 
when the antagonist was used in place of the morphine. 
Chronic exposure to a narcotic agonist undoubtedly 
causes biochemical and physiological changes that do 
not have time to occur in the 3 day morphine pellet 
rats. Thus, the method used to produce physical de- 
pendence to narcotics and the manner in which with- 
drawal is precipitated should be carefully considered. 
The changes that occur in brain ACh content and 
turnover are on different time scales, intensities, and 
can be in opposite directions. Furthermore, it is not 
valid to make comparisons between two modes of drug 
administration when drug dosages, brain levels, and 
time course are not comparable. Obviously such stud- 
ies need to be done. The present results merely em- 
phasize the need for more careful investigations and 
caution the indiscriminant use of morphine pellets 
without such quantitative data. 
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